NEW YORK — As the global medical community continues to evolve its understanding of aging and longevity, a significant shift is occurring in the landscape of women’s health. For decades, menopause was a topic relegated to the periphery of medical discourse, often treated as a silent season to be endured rather than managed. However, as of September 2025, a "new era" has emerged—one defined by personalization, proactive self-care, and a surge in non-hormonal, clinically backed interventions.
At the forefront of this movement is Dr. Alyssa Dweck, a board-certified gynecologist and the Chief Medical Officer at Bonafide Health. In a recent comprehensive dialogue regarding the state of the industry, Dr. Dweck and other experts highlighted how the modern woman—who is often at the peak of her professional career or physical fitness—is no longer willing to "sit out" of life due to the physiological disruptions of menopause.
Main Facts: Redefining the Menopausal Experience
Menopause is technically defined as the point in time twelve months after a woman’s last period. However, the transition leading up to it—perimenopause—and the years following it represent a complex biological shift. According to recent health data, nearly 1.3 million women in the United States enter menopause each year, yet a significant portion remains underserved by traditional medical models.
The primary challenge has historically been a binary choice in treatment: systemic hormone therapy (HT) or a "tough it out" mentality. While HT remains a gold standard for many, a substantial demographic of women either cannot take hormones due to medical contraindications (such as a history of certain cancers or blood clots) or simply prefer a non-pharmacological approach.
Bonafide Health has positioned itself as a disruptor in this space by bridging the gap between "natural" supplements and "pharmaceutical" rigor. Their approach focuses on hormone-free solutions that are subjected to the same level of scrutiny as prescription drugs, including randomized controlled trials (RCTs).
"Menopause isn’t a disease," Dr. Dweck emphasizes. "It’s a natural life event that impacts us all differently. For too long, women navigating menopause have been left with one-size-fits-all options."
Chronology: The Evolution of Menopause Management
To understand the current state of women’s health, one must look at the timeline of how menopause has been managed over the last several decades.
The Era of Silence (Pre-1960s)
Before the mid-20th century, menopause was rarely discussed in public or private. Women were expected to manage symptoms like "vapors" or "melancholy" with little to no medical assistance.
The Rise and Fall of Hormone Therapy (1960s–2002)
The 1960s saw the rise of "Feminine Forever" culture, promoting estrogen as a fountain of youth. However, the 2002 Women’s Health Initiative (WHI) study caused a massive pivot. Initial reports from the study suggested increased risks of breast cancer and heart disease, leading millions of women to abandon HT overnight.
The Re-evaluation and the "Hormone Gap" (2003–2020)
Over the next two decades, medical societies re-analyzed the WHI data, concluding that for women under 60 or within ten years of menopause onset, HT is generally safe and highly effective. Despite this, a "fear gap" persisted, and many women remained wary of hormones, leading to a desperate search for alternatives that actually worked.
The New Era of Clinical Botanicals (2021–Present)
By 2025, the industry has matured. Companies like Bonafide have moved beyond basic herbalism into "clinical botanicals." This involves identifying specific naturally derived ingredients, understanding their mechanism of action at a cellular level, and proving their efficacy through rigorous, placebo-controlled trials.
Supporting Data: The Science of Symptom Relief
The disruption caused by menopause is not merely anecdotal; it is rooted in profound physiological changes. The hallmark symptoms, known as vasomotor symptoms (VMS), include hot flashes and night sweats.
Vasomotor Symptoms and Physical Activity
For active women, VMS can be particularly debilitating. A sudden spike in core body temperature can make a routine five-mile run or a 60-minute yoga flow feel impossible. Dr. Dweck notes that when these symptoms are left untreated, women often retreat from the activities that keep them healthy and happy, leading to a secondary decline in cardiovascular and mental health.
The Clinical Standard
Bonafide’s product, Thermella, serves as a case study in this new era of data-driven relief. Unlike many over-the-counter supplements that rely on "borrowed science" (using studies done on isolated ingredients by other researchers), Thermella was studied as a finished product.
- Methodology: Randomized, double-blind, placebo-controlled trials.
- Result: Significant reduction in the frequency and severity of hot flashes without the use of exogenous hormones.
Sexual Health and Intimacy
Data also shows that menopause significantly impacts intimacy. A drop in estrogen leads to reduced blood flow to the pelvic region, causing vaginal atrophy and dryness. Furthermore, the age-related decline in testosterone can dampen libido.
- Revaree Plus: A hormone-free solution designed to restore moisture and tissue integrity.
- Ristela: A supplement focused on supporting blood flow, which clinical studies suggest can improve sexual satisfaction and orgasm potential.
Official Responses: Insights from Dr. Alyssa Dweck
In her capacity as a medical leader, Dr. Dweck advocates for a holistic but evidence-based approach to the transition. During her discussions, she addressed several critical areas of concern for women today.
On the Importance of Seeking Help:
"Relief from menopause symptoms is available—even for the most debilitating and nagging symptoms," says Dweck. She argues that seeking treatment is not a sign of weakness but a "powerful act of self-care." By managing symptoms, women can maintain the "rhythm" of their lives, staying "intertwined in the life they love."
On the Safety of Hormone Therapy:
Dr. Dweck is careful to balance the conversation. She acknowledges that for many, HT is a fantastic option. "For women who start hormone therapy within ten years of menopause or before age 60, the latest research suggests it can be both safe and beneficial in many ways, including bone health." However, her mission with Bonafide is to ensure that those who cannot or choose not to take hormones are not left behind.
On "Lesser-Known" Symptoms:
A major part of the new era of health is education. Dr. Dweck points out that many women don’t realize that symptoms like skin changes (acne or thinning), hair loss, joint aches, and even "burning tongue" are often linked to perimenopause. "If you’re noticing any of these subtle first symptoms… start tracking them. Observing patterns can help you identify whether you’re entering perimenopause and guide more productive conversations with your healthcare provider."
Implications: The Societal and Personal Impact
The implications of this shift in menopause management are far-reaching, affecting everything from workplace productivity to long-term public health.
1. Retention in the Workforce
As women in the menopausal age bracket are often in senior leadership positions, unmanaged symptoms can lead to early retirement or reduced hours. By providing effective, non-disruptive treatments, the "New Era" of health supports the retention of female talent in the global economy.
2. The Democratization of Expertise
Through "medically vetted education resources" and digital tools like symptomatic quizzes, companies are empowering women to become their own health advocates. This reduces the burden on an overstretched primary care system and ensures that the time spent with a doctor is focused and data-driven.
3. Redefining Aging
Perhaps the most significant implication is the psychological shift in how women view aging. Menopause is no longer being framed as the "beginning of the end," but rather a transition into a second act that can be just as vibrant and active as the first. The focus is on "performance"—not just for athletes, but for every woman navigating her daily life.
4. The Future of Research
The success of hormone-free, clinically studied products is likely to spur further investment into women’s health—a field that has historically been underfunded. As more companies adopt the "gold standard" of randomized controlled trials for supplements, the line between traditional and alternative medicine will continue to blur, much to the benefit of the consumer.
Conclusion
The landscape of women’s health in 2025 is unrecognizable compared to the start of the century. With leaders like Dr. Alyssa Dweck and innovators like Bonafide Health, the conversation has moved from "endurance" to "empowerment." By combining the best of nature with the rigor of science, the medical community is finally providing women with the tools they need to stay on the mat, on the trail, and fully engaged in their lives.
As Dr. Dweck concludes, "Intimacy, like movement, is meant to feel good." In this new era, the goal is simple: ensuring that every woman has the support she needs to feel good in her body, regardless of the season of life she is in.
About Bonafide Health:
Bonafide is a leading women’s health company specializing in relief from perimenopause and menopause symptoms. Committed to providing safe, hormone-free, and clinically studied relief, Bonafide works with a woman’s body to support her unique health needs through every stage of the transition.
